Related Experiment Videos
Cytokine patterns during dengue shock syndrome
Catharina Suharti1, Eric C M van Gorp, Wil M V Dolmans
1Department of Medicine, School of Medicine, Diponegoro University and Dr.Kariadi Hospital, Semarang, Indonesia.
European Cytokine Network
|December 6, 2003
Summary
Elevated interleukin-1 receptor antagonist (IL-1Ra) levels in dengue shock syndrome correlate with disease severity and mortality. Measuring IL-1Ra may serve as a crucial prognostic indicator in pediatric cases.
Area of Science:
- Immunology
- Pediatric Infectious Diseases
- Critical Care Medicine
Background:
- Dengue shock syndrome (DSS) is a severe manifestation of dengue infection.
- Cytokine dysregulation plays a critical role in DSS pathogenesis.
- Understanding specific cytokine profiles can aid in predicting disease outcomes.
Purpose of the Study:
- To investigate the dynamic patterns of key inflammatory cytokines and their antagonists in children with DSS.
- To determine the association between these cytokine levels and disease severity or mortality.
Main Methods:
- A prospective clinical study involving 50 children diagnosed with DSS.
- Plasma concentrations and ex vivo production of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), IL-6, interferon-gamma (IFN-gamma), and IL-1 receptor antagonist (IL-1Ra) were measured.
- Radioimmunoassay and ELISA were employed for cytokine quantification.
Main Results:
- Elevated IL-1 receptor antagonist (IL-1Ra) plasma concentrations and ex vivo production were observed during acute DSS, normalizing upon recovery.
- Pro-inflammatory cytokines TNF-alpha and IL-1beta showed depressed ex vivo production in acute DSS.
- Higher IL-6 and IL-1Ra levels, along with increased ex vivo IL-1Ra production, were significantly associated with mortality in non-survivors.
Conclusions:
- Interleukin-1 receptor antagonist (IL-1Ra) levels are significantly associated with mortality in dengue shock syndrome.
- IL-1Ra measurement can potentially serve as a valuable index for assessing disease severity in DSS.
- Further research into IL-1Ra's role could inform therapeutic strategies.